ClinicalTrials.Veeva

Menu

Customized Crosslinking: Safety and Efficacy in an Epithelium-off Accelerated-pulsated Protocol for Thin Keratoconus

I

Instituto de Oftalmología Fundación Conde de Valenciana

Status

Enrolling

Conditions

Keratoconus

Treatments

Procedure: Corneal Cross Linking

Study type

Interventional

Funder types

Other

Identifiers

NCT06159881
17 CI 09 015 008

Details and patient eligibility

About

The goal of this clinical trial is to document corneal ectasia stability in patients with keratoconus diagnosis treated with personalized cross linking energy. The main questions it aims to answer are:

  • Is it effective while using personalized (reduced) energy?
  • Is it safe for corneas thinner than 400 microns? Participants will be treated with personalized energy corneal cross linking and posteriorly, will attend subsequent follow-up consults

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Keratoconus diagnosed with corneal tomography/topography
  • Thinnest point pachymetry below 400 microns

Exclusion criteria

  • Previous corneal cross linking history
  • Corneal scars not allowing best corrected visual acuity of 20/100 or better
  • Previous corneal hydrops history
  • Psychomotor retardation history

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Personalized cross linking
Experimental group
Description:
Participants were treated with personalized energy cross linking according to their thinnest point corneal pachymetry
Treatment:
Procedure: Corneal Cross Linking

Trial contacts and locations

1

Loading...

Central trial contact

Itamar Vigderovich, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems